Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study-Reference-Cited by-同舟云学术

Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study

Published:2018-07-11 Issue:1 Volume:20 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Pisaniello Huai Leng^ORCID,Lester Susan,Gonzalez-Chica David,Stocks Nigel,Longo Marie,Sharplin Greg R.,Dal Grande Eleonora,Gill Tiffany K.,Whittle Samuel L.,Hill Catherine L.

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-018-1633-9.pdf

Reference55 articles.

1. Smith EU, Diaz-Torne C, Perez-Ruiz F, March LM. Epidemiology of gout: an update. Best Pract Res Clin Rheumatol. 2010;24(6):811–27.

2. Hak AE, Curhan GC, Grodstein F, Choi HK. Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis. 2010;69(7):1305–9.

3. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and nutrition examination survey III, 1988-1994. Am J Kidney Dis. 2002;40(1):37–42.

4. Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74(4):661–7.

5. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2008;67(7):960–6.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–Activity Relationships and Changes in the Inhibition of Xanthine Oxidase by Polyphenols: A Review;Foods;2024-07-26

2. Arthropathies microcristallines : incidence, prévalence et facteurs de risque;Revue du Rhumatisme;2024-07

3. Optimism as a predictor of poor comoliance with urate-lowering therapy in patients with gout: a prospective study;2024-06-28

4. Association between patient adherence and treat-to-target in gout: A cross-sectional study;Medicine;2024-02-23

5. Estimation of adherence to urate‐lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient‐reported dosing;British Journal of Clinical Pharmacology;2024-02-21